Rahul Shinde

8PUBLICATIONS

52CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markersChemical and thermal processes in energy and combustionImmunogenetics (incl. genetic immunology)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jun 03, 2026

Chemotherapy induces an IL1β-dependent neutrophil recruitment and activation that promote chemoresistance in metastatic ovarian cancer.

|Nov 03, 2025

Targeting Interactions Between Siglec-10 and α3β1 Integrin Enhances Macrophage-Mediated Phagocytosis of Pancreatic Cancer.

Pratima Saini, Gauri Mirji, S M Shamsul Islam

|Nov 21, 2024

Myeloid activation clears ascites and reveals IL27-dependent regression of metastatic ovarian cancer.

Brennah Murphy, Taito Miyamoto, Bryan S Manning

|Sep 18, 2023

Acetate acts as a metabolic immunomodulator by bolstering T-cell effector function and potentiating antitumor immunity in breast cancer.

Katelyn D Miller, Seamus O'Connor, Katherine A Pniewski

|Jul 13, 2023

The African-centric P47S Variant of <i>TP53</i> Confers Immune Dysregulation and Impaired Response to Immune Checkpoint Inhibition.

David C Stieg, Joshua L D Parris, Tyler Hong Loong Yang

|Sep 09, 2022

The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer.

Gauri Mirji, Alison Worth, Sajad Ahmad Bhat

Pageof 2

Frequent Collaborators

Gauri Mirji

Nan Zhang

Hsin-Yao Tang

Mohamed Abdel-Mohsen

Andrew Kossenkov

Toshitha Kannan

Daniel T Claiborne

Rugang Zhang

Qin Liu

Ben Z Stanger

Frequent Collaborators

Gauri Mirji

Nan Zhang

Hsin-Yao Tang

Mohamed Abdel-Mohsen